Eya1 phosphatase controls fate of embryonic lung epithelial stem cells
LOS ANGELES--(BUSINESS WIRE)-- Investigators at The Saban Research Institute of Children’s Hospital Los Angeles have provided the first evidence that Eya1 protein phosphatase is a crucial regulator of the development of embryonic lung epithelial stem cells.
Ahmed El-Hashash, PhD, senior research scientist, and David Warburton, MD, director of Developmental Biology and Regenerative Medicine at The Saban Research Institute. (Photo: Business Wire)
The correct functioning of lung epithelium is essential to life. Cellular polarity of lung epithelial cells, meaning that they have an asymmetrical orientation or a front and back, is crucial. Dysregulation of cell polarity has been associated with developmental disorders as well as cancer. Until now, little has been known about the mechanism that controls cell polarity, cell fate and self-renewal of embryonic lung epithelial stem cells. David Warburton, MD, director of Developmental Biology and Regenerative Medicine at The Saban Research Institute, and Ahmed El-Hashash, PhD, senior research scientist carrying out this study, will release their findings in the upcoming issue of Development.
“We know that loss of polarity in pulmonary epithelial cells is associated with lung cancer and chronic obstructive pulmonary disease. Knowing that Eya1 regulates polarity, we now have another target for intervening in those disease processes,” said Dr. Warburton.
They have determined that Eya1, a protein phosphatase, controls cell polarity, cell fate and self-renewal in the mouse embryonic lung epithelial stem cells. They have also provided the first evidence that these stem cells are polarized with characteristic perpendicular cell divisions.
In vivo and in vitro experiments showed that interfering with Eya1 phosphatase function resulted in defective epithelial cell polarity and mitotic spindle orientation; disrupted Numb, a cell fate determinant; and inactivated Notch signaling, which is involved in cell segregation and division, thereby establishing Eya1 as an important regulator in the development of embryonic lung stem cells.
“Identification of Eya1 mechanisms of regulating cell polarity, cell fate and self-renewal, will help to harness the regenerative potential of lung stem cells, and to identify novel targets for the prevention or rescue therapy of fatal lung disease, and for lung regeneration. This will also help to develop stem cell-based therapy to treat patients with lung diseases, ” said Dr. El-Hashash, PhD. “Solutions to the problems concerning regeneration of lung tissue for restoration of functional alveoli are at the cutting edge of identifying novel therapeutic options for lung diseases like COPD and fibrosis.”
For more information, visit www.CHLA.org. Follow us on Twitter, Facebook, YouTube and LinkedIn, or visit our blog: www.WeAreCHLA.org.
About Children’s Hospital Los Angeles
Children’s Hospital is one of only eight children’s hospitals in the nation – and the only one in the western United States – named to the national “Honor Roll” of children’s hospitals in the 2010 U.S. News & World Report rankings. Children’s Hospital is home to The Saban Research Institute, one of the largest and most productive pediatric research facilities in the United States and is one of America's premier teaching hospitals, affiliated with the Keck School of Medicine of the University of Southern California since 1932.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6664162&lang=en
CONTACT:
Children’s Hospital Los Angeles
Ellin Kavanagh
Office: 323-361-8505
[email protected]
KEYWORDS: United States North America California
INDUSTRY KEYWORDS: Stem Cells Health Biotechnology Genetics Hospitals Oncology Research Science
MEDIA:
| Photo |
| Ahmed El-Hashash, PhD, senior research scientist, and David Warburton, MD, director of Developmental Biology and Regenerative Medicine at The Saban Research Institute. (Photo: Business Wire) |